Cargando…
Lysyl Oxidase Is Downregulated by the EWS/FLI1 Oncoprotein and Its Propeptide Domain Displays Tumor Supressor Activities in Ewing Sarcoma Cells
Ewing sarcoma is the second most common bone malignancy in children and young adults. It is driven by oncogenic fusion proteins (i.e. EWS/FLI1) acting as aberrant transcription factors that upregulate and downregulate target genes, leading to cellular transformation. Thus, identificating these targe...
Autores principales: | Agra, Noelia, Cidre, Florencia, García-García, Laura, de la Parra, Juan, Alonso, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672102/ https://www.ncbi.nlm.nih.gov/pubmed/23750284 http://dx.doi.org/10.1371/journal.pone.0066281 |
Ejemplares similares
-
EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma
por: Cidre-Aranaz, Florencia, et al.
Publicado: (2015) -
TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma
por: Seong, Bo Kyung A., et al.
Publicado: (2021) -
Inhibition of angiogenesis in endothelial cells by Human Lysyl oxidase propeptide
por: Nareshkumar, Ragavachetty Nagaraj, et al.
Publicado: (2018) -
Insights into the structure and dynamics of lysyl oxidase propeptide, a flexible protein with numerous partners
por: Vallet, Sylvain D., et al.
Publicado: (2018) -
The role of FLI-1-EWS, a fusion gene reciprocal to EWS-FLI-1, in Ewing sarcoma
por: Elzi, David J., et al.
Publicado: (2015)